GlassScriptPhysician profile
James Kuo Li Liu
NPI 1720020977
$12,646.36
in general payments reported to CMS, 2019-2025
38 companies · $1,723 in 2025
The $1,723 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,580 · 2020: $1,417 · 2021: $2,428 · 2022: $1,651 · 2023: $1,765 · 2024: $2,082 · 2025: $1,723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,517 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33.41 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,517.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33.41 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,976.68 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,827.01 | 2019-2025 | |
| Amgen INC. | $1,159.65 | 2019-2025 | Repatha, Repatha |
| Amarin Pharma, INC. | $786.92 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $681.69 | 2021-2025 | |
| Pfizer INC. | $669.13 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $546.45 | 2019-2023 | |
| Esperion Therapeutics, INC. | $466.91 | 2020-2025 | Nexletol |
| Boston Scientific Corporation | $433.67 | 2019-2025 | Watchman Flx, Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $415.73 | 2019-2025 | Camzyos, Eliquis |
| Kowa Pharmaceuticals America, INC. | $406.47 | 2019-2024 | Livalo |
| Heartflow, INC. | $342.66 | 2023-2025 | Ffrct |
| Astrazeneca Pharmaceuticals LP | $328.95 | 2019-2024 | Farxiga |
| Scpharmaceuticals INC. | $321.06 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $319.30 | 2019-2024 | Jardiance |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $299.74 | 2019-2022 | |
| Novo Nordisk INC | $273.29 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $266.01 | 2021-2025 | Gallant, Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx |
| Merck Sharp & Dohme LLC | $217.60 | 2021-2025 | Verquvo, Capvaxive |
| Medtronic, INC. | $142.22 | 2024-2025 | Corevalve Evolut R, Mycarelink |
| Edwards Lifesciences Corporation | $123.44 | 2019-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic Vascular, INC. | $106.41 | 2019-2020 | |
| Abiomed | $96.48 | 2024-2025 | Impella |
| Medicure Pharma INC. | $69.46 | 2024-2025 | Zypitamag |
| Cvrx, INC. | $57.94 | 2024-2025 | Barostim Neo System |
| Lundbeck LLC | $44.66 | 2020-2021 | |
| Azurity Pharmaceuticals, INC. | $43.70 | 2023 | Edarbi |
| Baxter Healthcare | $34.41 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Regeneron Healthcare Solutions, INC. | $28.68 | 2019 | |
| Inspire Medical Systems, INC. | $28.30 | 2024 | Inspire |
| Impulse Dynamics (USA) INC. | $24.88 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.53 | 2019 | |
| Exact Sciences Corporation | $16.22 | 2023 | Cologuard Collection Kit |
| Lexicon Pharmaceuticals, INC. | $15.34 | 2024 | |
| Irhythm Technologies, INC. | $15.29 | 2024 | Zio Xt Patch, Zio Monitor |
| Masimo Corporation | $15.07 | 2025 | Patient Safetynet System |
| Endologix LLC | $12.77 | 2022 | |
| Gilead Sciences, INC. | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.